Good medicines first, ant worry-free 丨 Osicinib first-line drug resistance -MET amplification response strategy
*For medical professionals for reading referenceHow to deal with Osicininib to res...
Oshitinib first -line therapy in China ’s largest forward -looking real world research appeared in 2022 ESMO, which proves the efficacy and safety of Flaura research
*For medical professionals for reading referenceForesight Flourish research adds s...
Professor Wu Lin: From 5 real cases, the efficacy and safety of Savacinib in clinical practice
*For medical professionals for reading referenceIn August, MET excellent cases are...
New targets, new hope -these drugs at the 20122 WCLC conference are "hot"!
*For medical professionals for reading referenceQuickly punch the latest research ...
2022 WCLC 丨 NSCLC KRAS Huazhang sounds, four studies and one article speed view
*For medical professionals for reading referenceWhat are the wonderful studies of ...
2022 WCLC 丨 ≥2 Skin AE can be used as a prognostic logo?Update interpretation of Dakatinib research progress
*For medical professionals for reading referenceWhat did 2022 WCLC say about Dakat...
Professor Li Juan: How can patients with MET abnormal live alive?6 typical cases tell you
*For medical professionals for reading referenceIn July, MET excellent cases are e...
One picture understands: not all EGFR mutations, all are inserted from the 20th outer appende 20
*For medical professionals for reading referenceReveal the secret of EGFR mutation...
What is the occurrence of NSCLC, which is common and rare target mutations?What new progress?
*For medical professionals for reading referenceOne article clarified!The incidenc...
Professor Gongyou Ling: Savetinib's real world has great effects, win more benefits for patients with MET abnormalities
*For medical professionals for reading referenceIn June, MET excellent cases are e...
[2022 ASCO] Thick accumulation │HRR mutation MCRPC treatment research progress progress is based on analysis
*For medical professionals for reading referenceThe 2022 ASCO Annual Conference wa...
OS over 22 months!Braf V600E mutant colon cancer, liver metastasis "full star", three -line treatment layer breakthrough!
*For medical professionals for reading referenceThe prognosis is poor and the cura...